levocarnitine · Leadiant Biosci Inc · NDA 018948, 019257, 020182
Carnitor
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 020182-00130 Sep 2026
- 25 Oct 2026Generic approved · 020182-0012 Jul 2026
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 018948 · 001 · RLD | tablet, oral | 330MG | open |
| 018948 · 002 · discontinued | solution, oral | 1GM/10ML | open |
| 019257 · 001 · RLD | solution, oral | 1GM/10ML | open |
| 020182 · 001 · RLD | injectable, injection | 200MG/ML | open |